D-BSSE spinoff InSphero starts commercialisation of ‘organ-on-a-chip’ platform for drug testing

In a long-term collaborative research partnership with Andreas Hierlemann’s Bio Engineering Lab, the 2009-founded spinoff InSphero announces that they have completed the licence agreement for a microphysiological system, engineered to enable pharmaceutical and academic researchers to integrate 3D spheroid models in single- and multi-tissue organ networks for preclinical drug efficacy and toxicity testing applications.